Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Agent JNJ-56022473 in MDS and AML Patients Failing Hypomethylating Agent Based Therapy

NCT02992860 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT02992860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02992860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Agent JNJ-56022473 in MDS and AML Patients Failing Hypomethylating Agent Based Therapy
Lead sponsor
GWT-TUD GmbH
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2016
Completion date
October 31, 2018
Enrollment
25 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), myelodysplastic syndrome (mds)